showed a trendp = 0.708
In subgroup analysis of patients with blood eosinophil count ≥ 300 cells/μl, ICS use showed a trend to reduce the risk for exacerbation (IRR = 0.907, p = 0.708).
In subgroup analysis of patients with blood eosinophil count ≥ 300 cells/μl, ICS use showed a trend to reduce the risk for exacerbation (IRR = 0.907, p = 0.708).